Project Grant R01NS135833

Award Date 9/18/24
Completion Date 8/31/29
Dollars Obligated $654K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Kansas City, KS 66160, USA
Similar Awards
This federal Project Grant award of $517,494.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research at Duquesne University to investigate sex-specific differences in gene expression and RNA splicing patterns in the dorsal root ganglia during pain and pain relief. The key objectives are to define the differentially expressed RNA splice isoforms of the...
This federal Project Grant award in the amount of $351,097 was provided by the National Institute of Neurological Disorders and Stroke (NINDS), which is part of the National Institutes of Health (NIH). The grant was awarded under the NIH's Drug Use and Addiction Research Programs (CFDA 93.279) to establish a rigorous and supportive interdisciplinary training program in clinical pain research at Mass General Brigham (MGB) in Boston. The program will support a diverse pool of 8 postdoctoral...
This federal Project Grant award of $191,189 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to investigate sex differences in the bed nucleus of the stria terminalis (BNST) and their role in driving differential pain susceptibility. The principal investigator will carry out this research under the mentorship of Dr. Asaf Keller at the University of...
This $242,061 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) establishes an interdisciplinary clinical pain research training program at Mass General Brigham (MGB) in Boston. The program will support 8-12 postdoctoral fellows over 5 years, providing protected research time and dedicated training to expand the pool of early-career investigators capable of launching successful clinical...
This Project Grant award of $1,113,007 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA Program 93.865 - Child Health and Human Development Extramural Research, supports research to investigate the effects of gender-affirming hormone therapy (GAHT) on skeletal maturation in transgender individuals and how these effects may be mediated by modifications to the gut microbiome. The key objectives of this project are to: 1) determine the...
This Project Grant award of $6,154,752, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research aimed at understanding how menstrual pain and bladder hypersensitivity interact to promote chronic pelvic pain (CPP). The 3-year study, starting on September 17, 2024, will be conducted by Endeavor Health Clinical Operations, a non-profit research institute at Evanston Hospital. The project will...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $421,437 to the Regents of the University of Minnesota to conduct research on sex differences in spinal dopamine receptor 1 (DRD1) signaling and its contribution to neuropathic pain. The objective is to define the distribution and function of DRD1-expressing neurons in the dorsal...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $560,934 to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to conduct research on neural coding and control of pain detection in the somatosensory cortex. The 5-year research project, which commenced on April 1, 2025, aims to: Define...
This Project Grant award, with a total funding amount of $664,772, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award supports research to investigate the signaling mechanisms involving the neurotensin receptor 2 (NTSR2) and voltage-gated calcium channels (Cav2.3 and Cav2.2) as a novel, non-opioid analgesic pathway for the...
This federal Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on developing novel methods for selectively stimulating nociceptors (pain receptors) and measuring the brain's nociceptive-specific response in both healthy individuals and those with the chronic pain condition fibromyalgia. The $2,314,276 award to Emory University will fund the creation of a new...

This Project Grant award of $654,475 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will support research to characterize the impact of gender-affirming hormone therapy (GHT) on pain and pain-related symptoms in gender minority (GM) adults.

The key objectives are to: 1) Characterize the trajectory of pain and pain-related symptoms in GM adults taking GHT; 2) Perform quantitative sensory testing and functional brain imaging to examine the mechanisms underlying changes in pain and sensory sensitivity associated with GHT; and 3) Conduct qualitative studies on how GHT affects gender affirmation, psychological well-being, and the experience of pain. The University of Kansas Medical Center Research Institute, Inc. is the prime awardee, and they will collaborate with a sub-awardee, The Ohio State University, to execute the qualitative research component of the study.

Generated 7/1/25, 2:50 AM